My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AbbVie (NY:ABBV)

214.35 -0.67 (-0.31%)

Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

92 93 Next >

Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House ↗

July 25, 2024

Sentiment continues to be jittery, with the major index futures priming for a lower opening on Thursday as traders look ahead to the first read of second-quarter GDP data and more earnings. The tech...

Via Benzinga

Topics Government Stocks

7 Trustworthy Dividend Stocks to Steadily Build Your Portfolio ↗

July 24, 2024

With political rumblings poised to make things exciting, investors may turn to the stability of trustworthy dividend stocks.

Via InvestorPlace

AbbVie Earnings Preview: Will Humira's Expiry, New CEO Fuel A Bullish Surge? ↗

July 24, 2024

AbbVie will report Q2 earnings on Thursday. Investors watch for Humira impact and signs of recovery under new CEO.

Via Benzinga

Peeling Back The Layers: Exploring AbbVie Through Analyst Insights ↗

July 19, 2024

Via Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today ↗

July 18, 2024

Via Benzinga

AbbVie Unusual Options Activity ↗

July 17, 2024

Via Benzinga

AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now? ↗

July 22, 2024

The big pharma company's top drug is losing ground, but its dividend keeps rising.

Via The Motley Fool

10 Best Dividend Growth Stocks to Buy and Hold Forever ↗

July 21, 2024

Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance.

Via The Motley Fool

7 High-Yield Dividend Stocks to Help Pay Your Bills ↗

July 17, 2024

It’s time to stop actively generating wealth and let your money work for you with high-yield dividend stocks to buy.

Via InvestorPlace

3 Absurdly Cheap Stocks to Buy and Hold for Years ↗

July 17, 2024

You can buy these solid stocks at some attractive discounts right now.

Via The Motley Fool

7 High-Yield Dividend Stocks Beating Inflation ↗

July 16, 2024

High-yield dividend stocks are one of the surest paths to beating inflation as the cost of everything remains high in mid-2024.

Via InvestorPlace

Topics Economy

AbbVie Unusual Options Activity ↗

July 11, 2024

Via Benzinga

$1000 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today ↗

July 08, 2024

Via Benzinga

A Closer Look at AbbVie's Options Market Dynamics ↗

July 03, 2024

Via Benzinga

Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally ↗

July 21, 2024

The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.

Via Benzinga

3 Quantum AI Stocks That Could Redefine Computing ↗

July 16, 2024

Three quantum AI stocks could shape the future of computing, which means current market prices are very cheap.

Via InvestorPlace

Topics Artificial Intelligence

7 Recession-Proof Stocks to Shield Your Portfolio in 2024 ↗

July 16, 2024

Recession-proof stocks gain momentum as concerns about AI bubble grow and other factors contribute to needing to safeguard portfolios.

Via InvestorPlace

Topics Artificial Intelligence

3 Spinoff Stocks You Should Buy Now: July 2024 ↗

July 15, 2024

Spinoff stocks often take time to gain their footing in the market giving investors an opportunity to get in early.

Via InvestorPlace

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗

July 15, 2024

These companies stand out for their pedigrees, robust financials, and future growth prospects.

Via The Motley Fool

3 Dividend Growth Stocks to Buy and Hold ↗

July 14, 2024

What's better than a dividend? A dividend that's growing.

Via The Motley Fool

3 High-Yield Dividend Stocks That Still Look Like Bargains ↗

July 14, 2024

The prices of these reliable dividend payers haven't kept pace with the frothy stock market.

Via The Motley Fool

AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case ↗

July 12, 2024

AbbVie petitions the U.S. Supreme Court to protect its corporate records, arguing a lower court ruling threatens attorney-client privilege.

Via Benzinga

Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US ↗

July 11, 2024

The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical...

Via Benzinga

Topics Cannabis

10 Health Care Stocks Whale Activity In Today's Session ↗

July 10, 2024

Via Benzinga

Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem

July 10, 2024

Drug prices continue to rise, driving up healthcare costs. Pharmaceutical companies usually hike drug prices at the beginning of each year. In January 2024

Via MarketBeat

The 7 Best Warren Buffett Stocks to Buy in July 2024 ↗

July 09, 2024

Some investors may say value investing is dead, but its never a bad time to look at some of the best Warren Buffett stocks to buy

Via InvestorPlace

Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗

July 08, 2024

Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.

Via Talk Markets

The Smartest Dividend Stocks to Buy With $250 Right Now ↗

July 08, 2024

$250 will go a long way with these great dividend stocks.

Via The Motley Fool

EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO ↗

July 07, 2024

The GLP-1 drug market for obesity treatment is expected to skyrocket to $1 trillion or more, according to Maurits Pot, founder and CEO of Tema ETFs.

Via Benzinga

Topics ETFs

MarketBeat Week in Review – 7/1 - 7/5

July 06, 2024

The market was mostly quiet in a holiday-shortened week; that may change next week with the latest inflation readings and the kickoff of a new earnings season

Via MarketBeat

Topics Economy

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

92 93 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.